Fig. 1From: Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraThe recommended timing of delayed therapy for patients with suspected COVID-19 when preparing for CAR-T therapy. ALL: acute lymphoblastic leukemia; MM: multiple myeloma; NHL: non-Hodgkin lymphomaBack to article page